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In several families, multiple endocrine neoplasia type 
2A (MEN 2A) has been found in association with 
cutaneous lichen amyloidosis. It has been debated, 
however, whether the skin amyloidosis found in MEN 
2A families, localized exclusively in the interscapular 
area, represents the same anomaly as that found in 
autosomal dominant familial cutaneous lichen amy-
loidosis, which is more generalized. We screened two 
MEN 2A families with associated skin amyloidosis for 
germline mutations in the RET gene responsible for 
the MEN 2A cancer syndrome, and found the same 
mutation characteristic of MEN 2A in both families. 
C u taneous lichen amylo idosis (CLA) is a ra re disorde r characterized by deposits of amyloid in the papillary dermis. Sporadic as well as autosoma l dominant heredital), forms have been documented. Gagel ef (1 / (1989) reviewed 63 of these hereditary cases . Here 
we refer to the heredita l'y form as fa m ilia l cutaneous lichen 
amyloidosis (fam il ia l CLA). 
CLA- like sk in lesions have also been fo und in patients with 
multiple endocrine neoplas ia type 2A (M.EN 2A) (Gagel ef (1 /, 1989; 
Nu nziata ef (1 /,1989; Ferrer d (1 /.1991; Koussctr ef a/, 1991 ; Chabre 
ef a/, 1992; Robinson Cf (1/, 1992; Pacin i cf a/ , 1993). MEN 2A is a 
neop lastic syndrome characterized by C-cel l hyperplasia, medu llary 
thyroid carcinoma. pheochromocytoma , and parathyroid hyperpla-
sia. The disorder is caused by specific germ line mutations in the 
RET proto-oncogene (Donis-Kell er 1'1 (1/ , '1993; Mu lliga n 1'1 (1/. 
1993). 
Because patients have been fo und w ith CLA lesions in several 
MEN 2A f:,m ilies, it has been suggested that patients having 
sporadic or f:lmi lia l CLA shou ld be considered at risk for the MEN 
2A syndrome and therefore shou ld be tested fo r MEN 2A mutations 
(N unziata cf a/. 1989; Ferrer ef (1 /. 1991; C habre c/ (1/, 1992). Based 
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We also screened probands from three pedigrees with 
familial cutaneous lichen amyloidosis for RET muta-
tions. In none of the RET coding and flanking iu-
tronic sequences was a luutation detected. This most 
probably indicates that skin amyloidosis found in 
some MEN 2A families and familial cutaneous lichen 
amyloidosis are different conditions . Consequently, 
patients with apparent familial cutaneous lichen 
amyloidosis do not appear to be at risk for MEN 2A. 
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on the association of both of these conditions. RET ge ne l11utations 
have been thought responsible for the skin amyloidosis found in 
MEN 2A patients. We th eretore scree ned two ME N 2A ta milies 
with associated CLA and three families with tamilial CLA for RET 
germlinc mutations. 
MATERIALS AND METHODS 
Familial CLA The three f.1 mi lies participatin!; in this stud y had C LA in ar 
least twO !;eneratio ns (Fig 1). All afFected fami ly members were examined 
by a dermato lo!;ist. Light microscopic and e lectron microscopic evidence of 
;lI11 yloid \vas found ill skill biopsy spcc inl cn s fr0111 at least t\.\lO indiv iduals ill 
each of the fami lia l C LA f.1Il1iLies. FCLA-2 and FCLA-3. Altho ugh no 
e lectron nlicroscopic analysi s " 'as perf o fill cd 011 patient 1l1;}rc ri:l1 Fro111 f.1t11i ly 
FCLA-l. the dia!;nosis in this f.1 l1li ly was based on a charac teri stic clinica l 
p icture and on histopathologic and immunoAuorcsccn ce exa mina tio n of 
skill spccinlcll s. III all three f::'1111ilies, the C LA lesio ns were fOllnd tl1 a ilJi ), all 
the arllls and Ie!;s . 
MEN 2A/CLA Families Famil ies M EN 2A/CLA-1 and - 2 have bee n 
described before . Figure 2 shows th e re levant parrs of the pedigrees. Family 
MEN 2A/CLA-1 has been reporccd by Koussell' 1'1 al (1991) . who gave a 
detailed description of the C LA les io ns . Fami ly MEN 2A / C LA-2 has been 
described as fami ly 13 by Lips cl al (1994). Som e of the patients in this f;lInily 
appeared with lesions in the inte rscapular region o nl )" and we re clinic;l l1 y 
diagnosed as having CLA upon examination by a dermatologist. Light 
lI1i crosco l'ic eva luation of bio psy specimens of the lesions f;,iled. however. 
to detec t am yloid. 
Single-Strand Conformation Polymorphism (SSCP) Analysis 
High-mo lecnlar-we i!;ht DNA fi'om patients from f;nnilies MEN 2A I 
CLA-l. FCLA- 1 , FCLA-2, and FCLA-3 was used for SSCP anal ysis of all 20 
RET exollS . DNA amplification was carried o ut o n 150 IIg of DNA in I X 
Super Taq reaction bufFer usin!; 0.125 U of Super Taq (HT 13iotcchnolo!;y 
Ltd .. C ambridge . UK) in a total vo lume of 30 j.tI containin!; 20 JLM 
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Figurc 1. Pcdigrccs of faJl1iJics with familial cutancous lichcn 
amyloidosis (FCLA) includcd in this study. S"lid s)'lIIlw/s indi catc 
individu"ls ,J!Fected with C LA. 
deo" ycitidine triphosphate (dCTP). 200 fl-M deoxyadcnosinc triphosphate / 
thytnidi ne triphosphate/guan osin e triphosphate . and 1 !LCi of[a-J2 PJdCTP. 
The polymerase chain reaction (PC R) consisted of 30 cycles of 92°C fo r 
40 s. 72°C for 60 s. and anothe r 60 s for annealing at the "ppropt·iate 
tempcrature. Tablc I lists the primers (I ()() ng of each primer) used for each 
e)(on of thc RET gene. the anncaling tem peraturc, and the restriction 
cllzymes used w hen relativel y long PC R products were obtained. Electro-
pho resis was carri ed out in a 6')'u polyacrylamide gel under at least two 
differcnt conditions. Glycero l concentrations used were 0%,. 5'Yu, Or 10%. at 
4°C . 200C, or 30°C. rcspectivel y. Wc al so used Mutation Detection 
Enh ancer gel so lution (At-Biochcm . Malvern. PA) as a replacement for 
acrylam ide and glyce rol and ran the gels at 30°C in o. sx Tris-borate burrer 
at a maxjmum of 1750 V and 60 W in a temperature-regulated LK13 2010 
Macropho re dectro phoresis unit (Uppsala. Sweden). 
Polyn,orphisJ11s in thc RET GCl1C Intragcnic RET polYlllorphisms (sec 
Tablc U) were analyzed by carryillg o ut digestions with the t·estriction 
enzymes listed or. in the caSe of e"on 18. by SSC» anal ys is. 
Sequcncc Analysis For ;"1 fami lies. seq uence anal ys is was carried o ut 011 
exollS 10 and 1 I . w hich arc known to accoullt for 1I1 0 re than 95'1., of the 
1l1utations found in M EN 2A (Mulligan el til. 1994 : Scburrenecker "I til . 
·1994). In additio n. all SSCI' variants observed wcrc sequenced. For SSCI' 
and sequence an;.\ \ysis. the san1e prin1.e r sets \VCfC used. For sequcnt.:c 
analysis, however. one of the primers of cach se t was biotinylated. DNA 
amplifi cation W;IS ca tTied Out as desctibed ea rli er. PCR. produ cts were 
separated in a 2% low melting poillt agarose ge l. After cthidium bromide 
sta ining, bands were cut alit and iso lated with the Sephaglas Hand!>rep kit 
(Pharm;tcia 13iotech , Uppsala. Sweden). The twO single strands were 
separated usin g Dynal beads (DYNAL AS , Oslo. No rwa y). They were 
sequenced with the T7 sequencing k.it (Pharmacia Biotech) and 
I Q - 32 PldCTP. A 6% sequencing gel was used for electrophoresis. 
R.ESULTS 
RET Mutation Screening in MEN 2A1CLA Families A 
sea rch for mutations throughout the en tire RET gene by means of 
SSCP revealed in one [;I mil y (MEN 2 A/CLA-l) a conformation 
variant in exon 1 I in all afFected family members (MEN 2A and 
MEN 2A/CLA patients). Upon sequence analysis, this appeared to 
be ca used by tran sition T 1900---7 C , resulting in the substitutio n of 
a n arginine for a cys tein e a t codon 634 (Cys634---7 Arg) (Fig 3) . 
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Figure 2. Pedigrccs of familics with Illultiplc cndocrinc ncoplasia 
typc 2A (MEN 2A) and c utancous Iichcn ,uuyloidosis (CLA) in-
cluded in this study. S,, /id sYlllbols indicate individuals a1Fected with ME 
2A; , ""ded sYl/lbols show individuals "fFected with both MEN 2 A "lid CLA. 
T he nllmbe rs in pedigree 1 correspond to those or Fig 4. 
Sequence ana lys is of exons 10 and 11 of the RET gen e showed 
the same mutation , T1900---7C. in f.1l1lily MEN 2A/CLA-2 in all 
affected family members (MEN 2A an d MEN 2A/CLA patients). 
Confirmation of th e mutation was possible, as this l11uwtion creates 
a Hltrll site . Exon-1.1 alleles with the Illuwtion should ha ve an exrra 
Hilal site, giving rise to a PC R product that is 60 bp sh o rte r after 
digestion. Figure 4 shows res triction anal ys is of exon 11 for nim 
individuals frolll family MEN 2A/CLA-I. All afr"ected person 
indeed showed two bands, the wild-type and the 60-bp-shoncr 
mutant band. whereas no nafr"ected persons did not ha ve the restric-
tion site and showed only the wild-type band. 
RET Mutation Screening in Familial CLA Families SSCP 
analysis of all exons of the RET gene did not show a causative RET 
mutatio n, no r did seq uen ce analysis of exons 10 and I I . 
Haplotyping Using lntragenic Polymorphisms All fanLiIi~s 
were haplotyped for all of the in tragenic rnarke,·s listed in Table n. 
No specifIC polymorphism seemed to co-segregate with the familial 
CLA or MEN 2A/CLA phenotypes (data not shown). 
DlSCUSSION 
Phenotypic diversity due to Inlltations afFecting difr"erent domains QI' 
a gene product is a fj·cquent phenomenon known as allelic heter. 
ogeneity. The RET gene is a well-known example. Base-pair 
substitutions afFec ting o ne offive highl y conserved cys teine residues 
in the extracellular part of the protein arc associated with MEN 2/\ 
and hlmilial l11edullary th yro id ca rc ino ma (Mulligan ef (I I. 1 99~: 
SchuHcnecker eI (II, J 994). Furtherlllore, a missense mutation 
su bstituting threonine for methio nine at codon 9 18 in the tyrosine I 
kinase domain of the protein has been found to be lIniqueh 
associated with MEN 2B (Carlson cf aI, 1994; Eng cf 11/, 1994: 
I-1of.~tra cl aI, 1994). Mutations throughout the gene of o ne of the 
two alleles, presumably lead ing to in activation of thc protcin. h a\"~ 
been found responsibl e for a proponion of paticnts suR'Crin g froln 
Hirschsprung disease (Edery ef ai, 1994; R.omeo CI ai, 1994). Thr 
combined occurren ce of both MEN 2A and CLA in some f.1milie; 
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Table I. Pdmers Used in Single-Strand Conformation Polymorphism and Sequence Analysis of the 
RET Proto-Oncogene" 
Annealing 
E"on TCll lpcr.lrurc Ll!l1gth 
Numbl!r Forward Primer Reverse Primer (0C) (bp) 
R es triction 
Enzyme 
1 5' -GAGTGCCCCGGAACGTGCGT-3' S'CGCGTGC CACGGCAAACAG-3' 68 166 






3 5 ' -GGACCAGGGTTTACACCAGC-3' 5' -GCTTGTGTCAAGGGCTCGCA-3' 58 466 
4 5 ' -CCTTCCCGAGGAAACGGCT-3' 5' -CG AACTGTGGCCGG AGA CAG-3 ' 58 423 
5 5' -CCTAAGGTCTCTGGTTTTGG-3 ' 5' -AAGAGCGA CCACCTCATTTC-J ' 50 329 
6 5 ' -CATGAGGAAGCAGCCAGAGC-3 ' 5' -AGTGTCACCTGCCTCCCTGT -3 ' 57 333 
7 5 ' -CTGGCTAAGGTGTTCCCCTG-3' 5 ' -CCAGGCTCCAGAAG CTCCCA-3' 60 346 
8 5' -GCTGGTGCTGTTCCCTGTCC-,)' 5 ' -CCTCCCTTGGGCGTTTCCAG-3 ' 62 239 
<) 5 ' -AGTCTGCTGTGTGTCCTG-3' 5' -CCATGCCCTGATTAAACC-:l'G 50 158 
10 5' -GAGGCTGAGTGGG CTACGT C-3 ' 5' -AGACCTCTGTGGGG CTGGGA-3' 61 199 
11 5' -CTCTGCGGTGCCAAGCCTCA-3' 5 ' -TCTGTCTCCCCAGCTCGC T-3' 62 375 5(,, 1 
Mnd 
A ,In I 
,~"oll 
12 5 '-GCCTTCTTCCTCCCTGTCAT-:l , 5' -GAGACTCCCCAGGGCACTGT-3' 60 267 
13 5'-AACTTGGGGAAGGCGTGCA-3' 5'-AGAACAGGGCTGTATGGAGC-3 ' 57 277 
14 5'-AAGACCC AAGCTGCCTGACC-3 ' 5 ' -CTGGGTG CAGAGCC ATATGC -3 ' 60 294 
'15 5' -TGACCGCTGCTGCCTGCCA T -3' 5' -GCTTCCCAAGGACTGCCTGC-3 ' 6 1 25 1 
16 5' -AGGGATAGGGCCTGGGCTTC-3 ' 5' -TAACCTCCA CCCCAAGAGAG-J ' 58 192 
17 5 ' -AGCCACTCACTGGTCCTTCA-3' 5' -ATGGGGAGGGAATG CACACA-3' 57 240 
18 5' -CTGGCCCTGCTTGGATCATA-3 ' 5' -CAGCTTGTGGGAATTGGACC-3' 60 176 
19 5' -TAGTTGTGGCACATGGCTTG-3 ' 5' -GAGAGGAAGGA TAGTGCAGA-3' 59 260 .4 "nl 
Eml<. V 20 5 ' -CAAAGGGAGTTTTGCCAAGG-3' 5' -GCCGGTAGACTTTCCA TTCT-3 ' 56 3 11 
" pe R was don I.! ft 'l r al11piifil.: 'Hi o ll of c;u.: h of d lt.~ 211 eX-OI1!'. T he restriCtion ellzym es illdic:lI:c.d wcn: lIsed ir pelt prod l1 Cts Werc In ng-cr Ihan 250 bp. EX-OilS 1 ~ tld 4 Ilccdcd 10% 
dimcrh ylsul fox idc in the rea ctioll buller. 
and patients mig ht be assoc iated with specific RET mutations. We 
therefore anal yzed two f.11l1ilies. In patients of Ol1 e of these, MEN 
2A/CLA-'I , th e p,oesence of amyloid co uld be clearly demonmoated. 
Amyloid could no r be demonstrated ill specime ns I]-om the lesions 
of the pati ents from the other f' lI11il y. Because this is not a consistent 
feature of presumed CLA pati ents in previously reported MEN 
2A/CLA fa mi lies, however , and because all lesions were limited to 
the interscapular region. which is genenllly considered c haracteris-
tic for the assoc iation of MEN 2A and CLA. f.'l m il y MEN 2A/ 
CLA-2 was also included in t1li s stud y (Gagel el 11/. 1989; Nunziata 
e/ 11/, 1989; Ferrer eI (//, 199 1; Ko ussefr el 11/, 1991; C h abre i'I 11/, 
1992; Robinson el 11/, 1992; Pa cini I!I a/, 1993). 111 the cwo f.1 mi lies. 
we found the same RET mutatio n in codon 634 (Cys634--'> Arg). 
T h e mutatio n was present in all ME N 2A patients, som e of whom 
also had CLA. A Cys634 --'> Tyr mutation (G1901 --'> A) has been 
reported previousl y in another family with MEN 2A and CLA 
(Cecche rini el 11/, 1994b). Although all the mutations afrecr codon 
634, difre.oent amino acid substitutio ns resul t. T he muta tions found , 
notably Cys634--:> Arg, also occur tioeque ntl y in MEN 2A f; lI11 ilies 
without C LA lesionso Although an association between MEN 
2A/CLA and mutations in codo n 634 ma y be postu lated , the 
a bove-mentioned ;Irg unl ents make it hard to suggest a corre latio n 
between a specitic RET mutati on and the M EN 2A/CLA pheno-
type. 
It might be suggested that the joint occulTen ce of MEN 2A and 
e LA would be du e to the interaction of an apparently n o nc<1 usative 
polym o rphism and a disease- ca usin g mutation. as ha s been de-
scribed for the p.-ion gene (Goldfin·b CI 11/, 1992). In the RET gene. 
severa l common noncausat;ve po lym o rphi sms ha ve been found 
(Table II; Ceccherini cl 11/. 1994.1). None of the polYlllorphisl11s. 
however. seem ed to co-segregate with the M.EN 2A/CLA pheno-
typeo T hus. for an exp lanatio n of th e intrafinnilial phenotypic 
variabili ty. it m ay be necessary to look beyond the lT1utational-
polymorphi c gen otypeo DifFerentia l handlin g of the gen e product by 
the p:lloacrin e growth m echanislll ofa particular indi vidu al m ay a lrer 
the pathogenesis of the conditi on and cause pleiotropy of the 
phenotype (Ko ussefr cl 11/.1991; Kou sseff~ '1992). 
A search for RET mutations in patients fi·om three "CLA only" 
fil l1lilies did not revea l a l1lu tarion oth e.o t han already known 
non causative po lymorphislll s. We also looked for possible co-
segregation of these intragenic polymorphislllS with the cutaneous 
phenotype in these fami li es, but wcre unsuccessful. We the.oefore 
conclud e that RET is nor in volved in these cases of frllllilial CLA. 
O ur findings raise the question of whether the CLA fou n d in 
MEN 2A and famili a l CLA arc etiologica ll y sim il ar conditions. 
C lini ca ll y, there is a distinction in rhe affected sires . In ME N 2A 
paticnts, skin lesions arc a lways fou nd in the inre rscapular regio n. 
whereas in fami lia l CLA patients, skin lesions are more genera lized 
(R.obinson el 11/. 1992). Dysfu nction of the RET gen~ which in 
developing mi ce is expressed in the periphera l nervou s systc m 
(Schuchard t el 11/, 1994) . might lead to pruritus and subsequ cntl y to 
scratching and degeneration of keratinocyres. It h as been suggested 
th;.t prolonged m ech anica l fri ction may produce a macul ar amy-
loidosis. or "fi'iction am yloidosis" (Wong and Lin, 1988; Robinson 
1'1 n/, 1992). Because many c1wonic pruritic skin cond itions do not 
show skin am ylo idosis, however, th is etio logic m odel mi ght be an 
oversimpli ficat ion. 
T he c urrent results le nd suppo rt to the idea that skin lesions in 
Table II. Noncausative Nucleotide Changes Detected in the Coding Sequence of RET' 
Nucleotide Amino Acid Kcsrriction Controls Allele 1 
E"on C haJ'gc Substitution Site C hanged/' Tested Frequency 
2 GCG-> GCA Ala 45 En,~ 1 (+ ) 52 0 ,71 
3 GTC-> GTA Val 125 A 1/", 1 I ( - ) 49 0.98 
7 GCG-> GCA Ala 432 /3'<111 1 (+ ) 45 0,29 
11 GGT-> AGT GI)' 69 1->Ser /311,, 1 ( - ) 53 0.79 
13 CTT->CrG Leu 769 T"'11 ( - ) 46 0074 
15 TCC-> TCG Sl!r 904 RSill (+ ) 48 0.2 1 
18 CGC->TGC Arg982 ->Cys 90 0.98 
" Cccchcrini (., "I . 191) ·1. 
b -. Loss uf the II ICIHioJ1cd restri ction Sill.'; +. gain of the llIention ed rcsn-icrioll sitL' . 
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Figure 3. Partial sequence analysis of exon 11 in an affected 
member of family MEN 2A/CLA-1. Shown is the re levant part of the 
sequence contai nin g (hL! C)'s634~ Arg 1l11l tatlOTl. 
fami lia l C LA and MEN 2A/CLA patients arc different from genetic, 
clin ica l, and et io logic poin ts of view. Consequently, familia l CLA 
pati ents do not appear to be at ri sk for M EN 2A. To settle this iss ue 
defilliti ve ly, howeve r , m o re data arc needed. Mainly for thi s 
reason, it ma y still be reasonable for ph ys icians of (apparent) 
familia l CLA pa tients to ha ve their patients screened for I?ET 
muta tion s. 
IVr Ilwllk 11"'jillllilits al/(I/"'Iimlsji'r II,eir fIIoperal i"" ill I"is sl lld)' . O llr 1/",",,-, are 
als" dil l" 10 Mr. J.M. j allst'll Sc"iIlIH'nt-pall Vema lldDr.l-I.K.PI ...... 11(111 A lllslt,l 








~1 2 3 4 5 6 7 8 9 
375 
315 
Figure 4. HI",l restriction patterns of cxon 11 in the MEN 2A1 
CLA-l family mcmbers examined. The numbers correspond to those o f 
F ig 2. Afl'ceted ind ividuals show two bands bcca use of a" ex tra Hh,,1 s ite. 
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